Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England

Emma Copland; Martina Patone; Defne Saatci; Lahiru Handunnetthi; Jennifer Hirst; David P. J. Hunt; Nicholas L. Mills; Paul Moss; Aziz Sheikh; Carol A. C. Coupland; Anthony Harnden; Chris Robertson; Julia Hippisley-Cox

doi:10.1038/s41467-024-50151-0

Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England

Emma Copland, Martina Patone, Defne Saatci, Lahiru Handunnetthi, Jennifer Hirst, David P. J. Hunt, Nicholas L. Mills, Paul Moss, Aziz Sheikh, Carol A. C. Coupland, Anthony Harnden, Chris Robertson, Julia Hippisley-Cox^*

^*Corresponding author for this work

Research output: Contribution to journal › Correction › peer-review

1 Downloads (Pure)

Abstract

Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-47745-z, published online 27 May 2024 The original version of this article contained information on vaccine dose amount (full or half) in Table 2 and Supplementary Table 1. This has subsequently been found to be inaccurate due to inconsistent coding in the raw data. The vaccine dose amount has therefore been removed from Table 2 and Supplementary Table 1. This data was not used elsewhere in the analysis. An additional line has been added to the introduction to summarise vaccine doses that were given to the population: “Those aged 12 years and above were given a full dose of BNT162b2 vaccine (30 micrograms), and children aged 5–11 years were given a dose of 10 micrograms of BNT162b2 vaccine.” These changes have been made in the PDF and HTML versions of the article.

Original language	English
Article number	5723
Journal	Nature Communications
Volume	15
Issue number	1
DOIs	https://doi.org/10.1038/s41467-024-50151-0
Publication status	Published - 8 Jul 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41467-024-50151-0Licence: CC BY 4.0

Copland-etal-NC-2024-Author-correction-Safety-outcomes-following-COVID-19-vaccinationFinal published version, 361 KBLicence: CC BY 4.0

1 Article

Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England
Copland, E., Patone, M., Saatci, D., Handunnetthi, L., Hirst, J., Hunt, D. P. J., Mills, N. L., Moss, P., Sheikh, A., Coupland, C. A. C., Harnden, A., Robertson, C. & Hippisley-Cox, J., 27 May 2024, In: Nature Communications. 15, 1, 3822.
Research output: Contribution to journal › Article › peer-review

Open Access
File
1 Citation (Scopus)

9 Downloads (Pure)

Cite this

Copland, E., Patone, M., Saatci, D., Handunnetthi, L., Hirst, J., Hunt, D. P. J., Mills, N. L., Moss, P., Sheikh, A., Coupland, C. A. C., Harnden, A., Robertson, C., & Hippisley-Cox, J. (2024). Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England. Nature Communications, 15(1), Article 5723. https://doi.org/10.1038/s41467-024-50151-0

@article{d208b94b5e744571a645a5238d562b8c,

title = "Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England",

abstract = "Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-47745-z, published online 27 May 2024 The original version of this article contained information on vaccine dose amount (full or half) in Table 2 and Supplementary Table 1. This has subsequently been found to be inaccurate due to inconsistent coding in the raw data. The vaccine dose amount has therefore been removed from Table 2 and Supplementary Table 1. This data was not used elsewhere in the analysis. An additional line has been added to the introduction to summarise vaccine doses that were given to the population: “Those aged 12 years and above were given a full dose of BNT162b2 vaccine (30 micrograms), and children aged 5–11 years were given a dose of 10 micrograms of BNT162b2 vaccine.” These changes have been made in the PDF and HTML versions of the article.",

author = "Emma Copland and Martina Patone and Defne Saatci and Lahiru Handunnetthi and Jennifer Hirst and Hunt, {David P. J.} and Mills, {Nicholas L.} and Paul Moss and Aziz Sheikh and Coupland, {Carol A. C.} and Anthony Harnden and Chris Robertson and Julia Hippisley-Cox",

year = "2024",

month = jul,

day = "8",

doi = "10.1038/s41467-024-50151-0",

language = "English",

volume = "15",

journal = "Nature Communications",

issn = "2041-1723",

number = "1",

}

Copland, E, Patone, M, Saatci, D, Handunnetthi, L, Hirst, J, Hunt, DPJ, Mills, NL, Moss, P, Sheikh, A, Coupland, CAC, Harnden, A, Robertson, C & Hippisley-Cox, J 2024, 'Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England', Nature Communications, vol. 15, no. 1, 5723. https://doi.org/10.1038/s41467-024-50151-0

TY - JOUR

T1 - Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England

AU - Copland, Emma

AU - Patone, Martina

AU - Saatci, Defne

AU - Handunnetthi, Lahiru

AU - Hirst, Jennifer

AU - Hunt, David P. J.

AU - Mills, Nicholas L.

AU - Moss, Paul

AU - Sheikh, Aziz

AU - Coupland, Carol A. C.

AU - Harnden, Anthony

AU - Robertson, Chris

AU - Hippisley-Cox, Julia

PY - 2024/7/8

Y1 - 2024/7/8

N2 - Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-47745-z, published online 27 May 2024 The original version of this article contained information on vaccine dose amount (full or half) in Table 2 and Supplementary Table 1. This has subsequently been found to be inaccurate due to inconsistent coding in the raw data. The vaccine dose amount has therefore been removed from Table 2 and Supplementary Table 1. This data was not used elsewhere in the analysis. An additional line has been added to the introduction to summarise vaccine doses that were given to the population: “Those aged 12 years and above were given a full dose of BNT162b2 vaccine (30 micrograms), and children aged 5–11 years were given a dose of 10 micrograms of BNT162b2 vaccine.” These changes have been made in the PDF and HTML versions of the article.

AB - Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-47745-z, published online 27 May 2024 The original version of this article contained information on vaccine dose amount (full or half) in Table 2 and Supplementary Table 1. This has subsequently been found to be inaccurate due to inconsistent coding in the raw data. The vaccine dose amount has therefore been removed from Table 2 and Supplementary Table 1. This data was not used elsewhere in the analysis. An additional line has been added to the introduction to summarise vaccine doses that were given to the population: “Those aged 12 years and above were given a full dose of BNT162b2 vaccine (30 micrograms), and children aged 5–11 years were given a dose of 10 micrograms of BNT162b2 vaccine.” These changes have been made in the PDF and HTML versions of the article.

U2 - 10.1038/s41467-024-50151-0

DO - 10.1038/s41467-024-50151-0

M3 - Correction

SN - 2041-1723

VL - 15

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 5723

ER -

Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England

Abstract

UN SDGs

Access to Document

Fingerprint

Research output

Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England

Cite this